MARINE DRIVE MOBILE CORPORATION (OTCBB: MDMC) "Up 4.11% in morning trading"
Marine Drive Mobile Corp. engages in the development of transactional mobile commerce applications and services. The company’s technology platform matches merchants and consumers with the right products and services at the right time through electronic coupons. Its principal product includes eTeeoff.com, an e-couponing Website for golf industry merchants to create deals and offer their own electronic coupons. The company was formerly known as Sona Resources, Inc. and changed its name to Marine Drive Mobile Corp. in July 2011. Marine Drive Mobile Corp. was founded in 2007 and is headquartered in San Francisco, California.
BEACON REDEVELOPMENT INDUSTRIAL CORP. (OTC: BCND) "Up 100.00% in morning trading"
Beacon specializes in acquiring undervalued properties that offer the potential for above average return on investment along with multiple assets and development ability at distressed prices. The properties must offer recyclable/salvageable materials along with the potential for redevelopment and or desirable development potential. The company also seeks, along with the above formentioned, properties that have the possibility for governmental grants, tax rebates or deferments as part of their criteria for acquisition. Please visit the company's Web site at www.beaconredevelopment.com for all the latest information and updates.
NORTHWEST BIOTHERAPEUTICS INCORPORATED (OTC: NWBO) "Up 21.43% in morning trading"
Northwest Biotherapeutics, Inc. is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company is developing dendritic cell-based vaccines. The Company's lead clinical trial is a 240-patient trial in newly diagnosed Glioblastoma multiforme ("GBM"), the most aggressive and lethal form of brain cancer. The Company also previously received clearance from the FDA for a 612-patient Phase III trial in prostate cancer, and clearance from the FDA for Phase I trials in five other cancers. The Company has also conducted a Phase I/II trial with DCVax®-L for recurrent metastatic ovarian cancer.
About OTCPicks.com
OTCPicks.com, one of the leading penny stock Web sites, presents its daily Stocks to Watch and Midday Market Movers every weekday. In addition to all the latest penny stock news, OTCPicks also offers daily newsletters, unique commentaries and free profiles, alerts and investing tips.
The stocks presented above are available in OTCPicks.com's Free Daily Email Newsletter. For daily stock alerts go to www.otcpicks.com to sign up.
Disclosure: OTCPicks.com and affiliates are being compensated fifty thousand dollars by a third party (New Market Traders LTD) for a two week investor awareness campaign.
